Avient Corporation
NYSE:AVNTChemicals - Specialty
+$0.04 today
- Market cap
- $4.07B
- Beta
- 1.30
- P/E (TTM)
- 21.4
- EPS (TTM)
- $1.72
- Dividend yield
- 2.97%
Volume 0.55M
Average 0.74M
AVNT EBITDA Margin
EBITDA as a percentage of revenue.
Avient CorporationNYSE: AVNT
EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026
EBITDA Margin narrows to 14.4%
EBITDA Margin was 14.4% in Q3 FY2026, down 0.8 pp from a year earlier. On a trailing-twelve-month basis it was 14.8%, up 1.7 pp year over year. Over 3 fiscal years it widened by 6.6 pp.
Context
- EBITDA Margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 5 analysts of 18.0% for the fiscal year ending Dec 2026, up from 16.8% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 14.4%-3.1 pp QoQ
- Last fiscal yearDec 2025
- 16.8%+1.1 pp YoY
- LTMSep 2026
- 14.8%+1.7 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.8 pp | -1.1 pp | -0.3 pp |
| 1 year | +1.1 pp | +1.2 pp | +0.1 pp |
| 3 years | +6.6 pp | +1.4 pp | -5.2 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 16.8%
- Year-over-year change
- +1.1pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 16.8% | +1.1pp |
| FY2024 | 2024-12-31 | 15.7% | +3.3pp |
| FY2023 | 2023-12-31 | 12.5% | +2.2pp |
| FY2022 | 2022-12-31 | 10.2% | -2.6pp |
| FY2021 | 2021-12-31 | 12.8% | — |
EBITDA Margin vs competitors
How AVNT compares with its peers on the latest reported figures
- AVNT's LTM Sep 2026 EBITDA Margin of 14.8% is the 9th highest of the 11 companies compared; the peer median is 17.5%.
- Its year-over-year change of +1.7 pp is the 3rd highest of 11, against a peer median of -0.5 pp.
- Over three fiscal years its change of +6.6 pp compares with a peer median of -0.8 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 33.9% | +26.2 pp | +0.7 pp | |
| LTM Jun 2026 | 23.6% | -3.5 pp | -1.0 pp | |
| LTM Jun 2026 | 20.6% | +47.2 pp | -49.2 pp | |
| LTM Jun 2026 | 19.0% | -2.3 pp | +9.0 pp | |
| LTM Jun 2026 | 17.7% | +0.9 pp | -0.7 pp | |
| LTM Aug 2026 | 17.4% | -0.9 pp | -1.0 pp | |
| LTM Sep 2026 | 16.1% | -0.0 pp | +3.9 pp | |
| LTM Aug 2026 | 15.2% | +1.3 pp | +2.1 pp | |
| LTM Sep 2026 | 14.8% | +1.7 pp | +6.6 pp | |
| LTM Jun 2026 | 1.1% | -9.6 pp | -16.7 pp | |
| LTM Jun 2026 | -39.6% | -63.9 pp | -75.9 pp | |
| Peer median (excluding AVNT) | 17.5% | -0.5 pp | -0.8 pp | |
Competitors are the stored peer set for AVNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.32B | 3.4B | 3.14B | 3.24B | 3.26B |
| Cost of Revenue | 2.37B | 2.51B | 2.24B | 2.18B | 2.2B |
| Gross Profit | 943.8M | 882.7M | 902.7M | 1.06B | 1.06B |
| Gross Margin | 28.5% | 26.0% | 28.7% | 32.6% | 32.5% |
| Research & Development | 0 | 84.9M | 90.3M | 98.7M | 0 |
| Selling, General & Admin | 664.1M | 639.4M | 590.9M | 727.4M | 695.4M |
| Operating Expenses | 664.1M | 639.4M | 681.2M | 727.4M | 854.7M |
| Depreciation & Amortization | 145.9M | 163.1M | 188.8M | 179.7M | 185.9M |
| EBITDA | 424.6M | 346.7M | 391.4M | 510.1M | 548.7M |
| EBITDA Margin | 12.8% | 10.2% | 12.5% | 15.7% | 16.8% |
| Operating Income | 279.7M | 243.3M | 221.5M | 329.3M | 203.5M |
| Operating Margin | 8.4% | 7.2% | 7.0% | 10.2% | 6.2% |
| Interest Income | 17.5M | 34M | 0 | 0 | 0 |
| Interest Expense | 105.1M | 182.3M | 115.3M | 105.6M | 98.6M |
| Other Income / Expenses | (76.2M) | (179.5M) | (134.2M) | (104.5M) | (91.8M) |
| Income Before Tax | 203.5M | 63.8M | 87.3M | 224.8M | 111.7M |
| Pre-Tax Margin | 6.1% | 1.9% | 2.8% | 6.9% | 3.4% |
| Income Tax Expense | 51.9M | (19.3M) | 11M | 54.1M | 28.1M |
| Net Income | 230.8M | 153M | 75.7M | 169.5M | 81.9M |
| Net Margin | 7.0% | 4.5% | 2.4% | 5.2% | 2.5% |
| EPS (Basic) | 2.53 | 7.71 | 0.83 | 1.86 | 0.90 |
| EPS (Diluted) | 2.51 | 1.66 | 0.82 | 1.84 | 0.89 |
| Weighted Avg Shares | 91.4M | 91.2M | 91.1M | 91.3M | 91.5M |
| Weighted Avg Shares (Diluted) | 92.1M | 92.2M | 91.8M | 92M | 91.8M |
Avient Corporation
NYSE:AVNT
Intrinsic Alpha fair value
Locked
Current Price
$44.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.